Despite intensive basic and clinical research, treatment of sepsis and related organ dysfunction consists largely of supportive care, as all novel anti-inflammatory therapeutic approaches, including the recently withdrawn activated protein C, have failed to improve the outcome of patients with sepsis and multiple organ dysfunction [6]–[8]. The gene discussed is PROC; the disease is Sepsis.